FDA authorizes chloroquine for use in treating coronavirus

$%name FDA authorizes chloroquine for use in treating coronavirus by Authcom, Nova Scotia\s Internet and Computing Solutions Provider in Kentville, Annapolis Valley$

The FDA issued an emergency authorization of anti-malaria drugs for coronavirus treatment, as a vaccine is at least a year away.
Chloroquine and hydroxychloroquine were brought to the public’s attention by President Trump’s recent remarks, and they have shown promise in COVID-19 therapy in a few limited studies.
COVID-19 patients aren’t advised to self-medicate; they should seek proper medical attention if they suspect a coronavirus infection.
Visit BGR’s homepage for more stories.

The anti-malarial drugs chloroquine and hydroxychloroquine have come to the public’s attention following Trump’s recent remarks. The president said a few days ago that he felt “good” about them when it comes to treating the novel coronavirus, urging the FDA to speed up their use in COVID-19 therapies. Since then, we’ve heard of all sorts of things about the drugs. A man killed himself ingesting the wrong type of chloroquine-based chemical, and another coronavirus patient thinks the drug saved his life. On top of that, the World Health Organization (WHO) included the two drugs into a massive worldwide trial that’s looking at four different types of therapies that could speed up the recovery of COVID-19 patients. It’s no wonder that the Food and Drug Administration (FDA) finally issued an emergency use authorization for hydroxychloroquine and chloroquine related to coronavirus treatment.

Continue reading…

Today’s Top Deals

Trending Right Now:

FDA authorizes chloroquine for use in treating coronavirus originally appeared on BGR.com on Mon, 30 Mar 2020 at 09:46:26 EDT. Please see our terms for use of feeds.